Ganesh Rao, M.D.
Ganesh Rao, M.D.
Marc J. Shapiro Professor and Chair
- Marc J. Shapiro Professor and Chair
Baylor College of Medicine
Houston, TX US
- Baylor College of Medicine (Clinic)
Department of Neurosurgery
Houston, TX 77030
Phone: (713) 798-4696
- Advanced Training from MD Anderson Cancer Center
- 01/2006 - Houston, TX United States
- Advanced Training from University Of Utah
- 01/2005 - Salt Lake City, UT United States
- M.D. from University Of Arizona College Of Medicine
- 01/1998 - Tucson, AZ United States
- Board Recertification 2019
- Re-Certification American Board of Neurological Surgery
- Board Certification 2009
- American Board of Neurological Surgery
Honors & Awards
- Congress of Neurological Surgeons (10/2018 - 10/2019)
Professional StatementI am a board-certified neurosurgeon with a specialty interest in neurosurgical oncology. Prior to being recruited as Chair of the Department of Neurosurgery at Baylor College of Medicine, I practiced neurosurgery at The University of Texas MD Anderson Cancer Center for 15 years. I have years of experience treating patients with brain and spine tumors. I treat primary brain tumors including low-grade glioma, glioblastoma, and meningioma, as well as metastatic brain tumors. I have also used advanced surgical techniques and novel technologies to treat brain tumors including stereotactic navigation, awake surgery, endoscopy, stereotactic radiosurgery, and laser interstitial thermal therapy. I perform basic and clinical research to understand the causes of glioma, the most common and aggressive form of brain cancer. I am funded by the National Institutes of Health for this research. My primary goal is to provide the best care for my patients. This includes not only the best surgery possible but also compassionate care before and after surgery with continuous contact with the medical team. Professionally, I have served as President of the Congress of Neurological Surgeons (2018-2019) and was the Residency Program Director for the Baylor College of Medicine Neurosurgery Residency Program.
- "Anti-PD-1 induces M1 polarization in the glioma microenvironment and exerts therapeutic efficacy in the absence of CD8 cytotoxic T cells." Clinical Cancer Research.; Pubmed PMID: 32554515
- "Role of CX3CR1 Signaling in Malignant Transformation of Gliomas." Neuro-Oncology.; Pubmed PMID: 32236410
- "The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma." Journal of the National Cancer Institute.; Pubmed PMID: 29947810
- "Sox9 directs divergent epigenomic states in brain tumor subtypes." Proc Natl Acad Sci USA. 2022 Jul 19; Pubmed PMID: 35858326
- Congress of Neurological Surgeons
- American Association of Neurological Surgeons
- Society of Neurological Surgeons
- American Academy of Neurological Surgeons
- Society for Neuro-Oncology
- Modeling Malignant Progression in Glioma - #R01NS094615 (03/31/2016 - 04/30/2023) National Institutes of Health
- Laser Interstitial Thermal Therapy for the Treatment of Glioblastoma - #R21NS123589 (07/01/2021 - 12/31/2023) NINDS
- Modulation of Microglia and T Cell Interactions in Malignant Glioma - #R01CA120813 (07/07/2021 - 07/06/2026) NCI
- Cellular and Molecular Mechanisms of GBM Infiltration - #R01 NS124093 (03/15/2022 - 02/28/2027) NINDS
- Surgery for primary brain tumors
- I specialize in the surgery of primary brain tumors, in particular I am an expert in the surgical removal of low-grade gliomas and glioblastoma using advanced surgical techniques including motor and speech mapping during awake surgery.
- Surgery for metastatic brain tumors
- I use advanced surgical techniques to remove metastatic brain tumors. I have published studies that have helped create the standard of care for the management of metastatic cancer to the brain.
Log In to edit your profile